Nabeel Ahmad

Nabeel Ahmad

Auto-generated profile, based on publicly available information

Nabeel Ahmad

School of chemical and materials engineering, National university of science and technology) NUST, Islamabad, Pakistan

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2019 in ACS Nano
Verified
Journal Article
Closed access
NANabeel Ahmad
Nabeel Ahmad
MBMarta Bon
Marta Bon
DPDaniele Passerone
Daniele Passerone
RERolf Erni
Rolf Erni

13 October 2021 in Journal of Materials Chemistry A
Verified
Journal Article
Open access
PDF file
HAHaris Masood Ansari
Haris Masood Ansari
ABAdam Stuart Bass
Adam Stuart Bass
NANabeel Ahmad
Nabeel Ahmad
VBViola I. Birss
Viola I. Birss
In situ exsolved Fe–Ni nanoparticles anchored on a (La0.3Ca0.7)0.95Fe0.7Cr0.25Ni0.05O3−δ parent perovskite surface significantly enhance the CO oxidation kinetics, thus reaching excellent activity of the CO2 reduction reaction.

31 August 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SGSaima Gulshan
Saima Gulshan
SSshahid shah
shahid shah
PSPervaiz Akhtar Shah
Pervaiz Akhtar Shah
Muhammad IrfanMuhammad Irfan
Muhammad Irfan
MUMalik Saad Ullah
Malik Saad Ullah
OAOsama Alwassil
Osama Alwassil
Depression is the major mental illness which causes along with loss of interest in daily life, a feeling of hopelessness, appetite or weight changes, anger and irritability. Due to the hepatic first-pass metabolism, the absolute bioavailability of fluvoxamine (FVM) after oral administration is about 50%. By avoiding the pre-systemic metabolism, nasal delivery would boost bioavailability of FVM. Additionally, the absorption is anticipated to occur more quickly than it would via the oral route because of the existence of microvilli and high vasculature. A nonionic surfactant, cholesterol and an arachidonic acid-carboxymethyl chitosan (AA-CMCS) conjugate were used to develop FVM-loaded novasomes. To investigate the effects of surfactant concentration, AA-CMCS conjugate concentration and stirring speed on the novasomes’ characteristics, a Box–Behnken design was used. The dependent variables chosen were zeta potential, polydispersity index and particle size. The AA-CMCS conjugate was confirmed by 1H-NMR and FTIR. Using Design Expert software (version 7; Stat-Ease Inc., Minneapolis, MN, USA), novasomes were further optimized. The chosen optimal formulation (NAC8) was made up of AA-CMCS conjugate, Span 60 and cholesterol. Particle size, zeta potential and PDI values for NAC8 formulation were 101 nm, −35 mV and 0.263, respectively. The NAC8 formulation’s DSC and TGA analysis demonstrated that the medication had been uniformly and amorphously distributed throughout the novasomes. The NAC8 formulation showed 99% and 90% FVM release and permeation, respectively, and the novasome adherence time was 24 h. An improved antidepressant effect along with five-fold increase in bioavailability of FVM was observed after trans-nasal administration of NAC8 formulation compared to the reference commercially available Flumin® tablets. FVM-loaded novasomes administered via the nasal route may therefore constitute an advancement in the management of depression.

8 August 2019 in The Journal of Chemical Physics
Verified
Journal Article
Closed access
PDF file
MBM. Bon
M. Bon
NAN. Ahmad
N. Ahmad
RER. Erni
R. Erni
DPD. Passerone
D. Passerone
The validation of embedded atom models (EAMs) for describing nanoalloys requires the verification of both a faithful description of the individual phases and a convincing scheme for the mixed interactions. In this work, we present a systematic benchmarking of two widely adopted EAM parameterizations, i.e., by Foiles [Phys. Rev. B 33, 7983 (1986)] and by Zhou [Phys. Rev. B 69, 144113 (2004)] with density functional theory calculations for the description of processes at Ag@Au nanoalloy surfaces and nanoclusters.

6 August 2025 in Optical Materials
Verified
Journal Article
Closed access
JCJi-Ho Choi
Ji-Ho Choi
YHYoon-Young Huh
Yoon-Young Huh
CJChang Hyun Jo
Chang Hyun Jo
NANabeel Ahmad
Nabeel Ahmad
MSMohsin Saleem
Mohsin Saleem
Jung-Hyuk KohJung-Hyuk Koh
Jung-Hyuk Koh

5 July 2023 in Molecules
Verified
Journal Article
Open access
PDF file
HINA YOUNISHINA YOUNIS
HINA YOUNIS
HKHafeez Ullah Khan
Hafeez Ullah Khan
SMSafirah Maheen
Safirah Maheen
MUMalik Saad Ullah
Malik Saad Ullah
SSshahid shah
shahid shah
GAGhulam Abbas
Ghulam Abbas
The current study focused on the fabrication of a well-designed, biocompatible, physically stable, non-irritating and highly porous gelatin scaffold loaded with controlled-release triamcinolone acetonide (TA) and econazole nitrate (EN) co-loaded into mesoporous silica nanoparticles (EN-TA-loaded MSNs) to provide a better long-lasting antifungal therapeutic effect with minimal unfavorable effects. Optimization of the MSNs-loaded scaffold was performed using central composite rotatable design (CCRD), where the effect of gelatin concentration (X1), plasticizer (X2) and freezing time (X3) on the entrapment of EN (Y1) and TA (Y2) and on the release of EN (Y3) and TA (Y4) from the scaffold were studied. The significant compatibility of all formulation ingredients with both drugs was established from XRD, DSC and FT-IR spectra analyses while SEM and zeta studies represented a very precise unvarying distribution of the loaded MSNs in the porous structure of the scaffold. The stability of the optimized scaffold was confirmed from zeta potential analysis (−16.20 mV), and it exhibited higher entrapment efficiency (94%) and the slower (34%) release of both drugs. During in vitro and in vivo antifungal studies against Candida albicans, the MSNs-loaded scaffold was comparatively superior in the eradication of fungal infections as a greater zone of inhibition was observed for the optimized scaffold (16.91 mm) as compared to the pure drugs suspension (14.10 mm). Similarly, the MSNs-loaded scaffold showed a decreased cytotoxicity because the cell survival rate in the scaffold presence was 89% while the cell survival rate was 85% in the case of the pure drugs, and the MSNs-loaded scaffold did not indicate any grade of erythema on the skin in comparison to the pure medicinal agents. Conclusively, the scaffold-loaded nanoparticles containing the combined therapy appear to possess a strong prospective for enhancing patients’ adherence and therapy tolerance by yielding improved synergistic antifungal efficacy at a low dose with abridged toxicity and augmented wound-healing impact.